Serum parameters predict the severity of ultrasonographic findings in non-alcoholic fatty liver disease. (Q51350390)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23060397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

Serum parameters predict the severity of ultrasonographic findings in non-alcoholic fatty liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23060397%20AND%20SRC:MED&resulttype=core&format=json

non-alcoholic fatty liver

10 March 2020

main subject

1 reference

metabolic dysfunction–associated steatotic liver disease

inferred from title

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23060397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Mohsen Razavizade

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23060397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Raika Jamali

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23060397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Abbas Arj

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23060397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

1 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23060397%20AND%20SRC:MED&resulttype=core&format=json

Hepatobiliary & Pancreatic Diseases International

10 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23060397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23060397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23060397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

513-520

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23060397%20AND%20SRC:MED&resulttype=core&format=json

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

MRI and ultrasound for hepatic fat quantification:relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

The utility of radiological imaging in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Non-alcoholic fatty liver disease: further expression of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively?

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Prevalence and etiology of abnormal liver tests in an adult population in Jilin, China

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Role of radiologic modalities in the management of non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Cardiovascular disease risk profiles.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Fatty liver in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Metabolic predictors for early identification of fatty liver using doppler and B-mode ultrasonography in overweight and obese adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Viral and host causes of fatty liver in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Serum oxidized-LDL is associated with diabetes duration independent of maintaining optimized levels of LDL-cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Role of tissue disorder markers in the evaluation of disease progress and outcome prediction: a prospective cohort study in non‐cardiac critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Comparison of waist-to-hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type-2 diabetes: a prospective cohort study from ADVANCE.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Focal hepatic fatty infiltration as a cause of pseudotumors: ultrasonographic patterns and clinical differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Could inflammatory markers help diagnose nonalcoholic steatohepatitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2812%2960216-1

7 January 2021

10.1016/S1499-3872(12)60216-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23060397%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23060397%20AND%20SRC:MED&resulttype=core&format=json